We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic ... Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa. Show more
SOLANA BEACH, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases...
SOLANA BEACH, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases...
Fiscal year 2023 net product sales from prescriptions totaled approximately $5.2M, a 107% increase from 2022 Company projects $14M in net revenue for 2024 SOLANA BEACH, Calif., March 14, 2024...
SOLANA BEACH, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases with an...
SOLANA BEACH, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.04 | -8.03212851406 | 0.498 | 0.5499 | 0.431 | 8517 | 0.44575237 | CS |
4 | -0.212 | -31.6417910448 | 0.67 | 0.675 | 0.4159 | 21912 | 0.53729278 | CS |
12 | -0.1915 | -29.4842186297 | 0.6495 | 0.76 | 0.4159 | 41866 | 0.64812838 | CS |
26 | -0.702 | -60.5172413793 | 1.16 | 1.49 | 0.4159 | 39371 | 0.77481242 | CS |
52 | -1.462 | -76.1458333333 | 1.92 | 2.3999 | 0.4159 | 29864 | 1.05074645 | CS |
156 | -1.302 | -73.9772727273 | 1.76 | 5.96 | 0.2261 | 578890 | 1.1287195 | CS |
260 | -0.252 | -35.4929577465 | 0.71 | 6.0628 | 0.2261 | 564888 | 1.69124484 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions